Mar 28, 2012
The Peninsula Shanghai
32 Zhongshan Dong Yi Road
Shanghai, China
Cost: $1950 per person
Dress Code: Business Attire
To reserve your hotel room at the Peninsula Shanghai, please contact Iris Chen via (86-21) 2327 2888 EXT: 7626 or (86-21) 2327 6588 (RSVN direct line). Please let them know you are with the “Shanghai CEO Conference”.
| Time | Agenda |
|---|---|
| March 28, 2012 | |
| 4:00 - 4:30 pm | Registration |
| 4:30 - 4:45 pm | Welcome and Opening Co-Host Remarks Paul Bolno, GlaxoSmithKline; Nancy Chang, OrbiMed; Chun-lin Chen, Medicilon; Li Chen, Hua Medicine; Michelle Dipp, OvaScience; Samantha Du, Ge Li, WuXi Pharma; Joel Marcus, Alexandria Real Estate; Paul Schimmel, Scripps; Goro Takeda, Sofinnova Ventures; Christoph Westphal, Verastem; Steve Yang, Astrazeneca; Jingwu Zang, GlaxoSmithKline |
| 4:45 - 5:15 pm | Opportunities and Challenges in China Richard Sackler, Chairman & Owner, Purdue Pharma Moderator: Ge Li, WuXi Pharma |
| 5:15 - 5:45 pm | How Healthcare Innovation is Transforming Asia John Oyler, Beigene; Paul Schimmel, Scripps Research Institute |
| 5:45 - 6:15 pm | Lifetime Achievement Award Nominees: Chun-Lin Chen, Medicilon; Ge Li, WuXi Pharma |
| 6:15 - 7:15 pm | Networking Cocktails and Hors d’oeuvres Co-hosted by: Paul Bolno, GlaxoSmithKline; Nancy Chang, OrbiMed; Chun-lin Chen, Medicilon; Li Chen, Hua Medicine; Michelle Dipp, OvaScience; Samantha Du, Ge Li, WuXi Pharma; Joel Marcus, Alexandria Real Estate; Paul Schimmel, Scripps; Goro Takeda, Sofinnova Ventures; Christoph Westphal, Verastem; Steve Yang, Astrazeneca; Jingwu Zang, GlaxoSmithKline |
| March 29, 2012 | |
| 7:00 - 7:45 am | Registration and Networking Breakfast |
| 7:45 - 8:30 am | Welcome and Opening Remarks |
| 8:30 - 9:15 am | Healthcare Investor Perspective Modassir Choudhry, Passport Capital; Francesco De Rubertis, Index Ventures; Steve Knight, Fidelity; Thomas Roberts, Farallon Capital Management Moderator: Arthur Mok, Ropes & Gray, LLP |
| 9:15 - 10:00 am | Business Development Tao Fu, Johnson & Johnson; Shaun Grady, Astrazeneca; Joe McCracken, Roche; David Nicholson, Merck Moderator: Samantha Du |
| 10:00 - 10:30 am | Networking Break |
| 10:30 - 11:15 am | Biotech R&D Luc Dochez, Prosensa Therapeutics; Carl Firth, ASLAN Pharmaceuticals; Robert Gould, Epizyme; Frank Jiang, Sanofi-Aventis; Mathai Mammen, Theravance; Jason Mann, Barclays Capital; Sam Waksal, Kadmon Corp. Moderator: Michelle Dipp, OvaScience |
| 11:15 - 12:00 pm | Partnering Between US/China Paul Bolno, GlaxoSmithKline; Chun-Lin Chen, Medicilon; Art Pappas, Pappas Ventures Moderator: Joel Marcus, Alexandria Real Estate Equities |
| 12:00 - 1:00 pm | Networking Lunch |
| 1:00 - 1:45 pm | US Biotech CEO Stephen Collins, Neurotherapeutics Pharma; Oliver Fetzer, Cerulean Pharma; Lonnie Moulder, Tesaro; Chris Varma, Blueprint Medicines Moderator: Marc Grasso, UBS |
| 1:45 - 2:30 pm | Venture Capital Rich Aldrich, Longwood Fund; Nancy Chang, OrbiMed; Taro Inaba, Mitsui & Co.; Robert Nelsen, Arch Venture; Yi Shi, Lilly Asia Ventures; Goro Takeda, Sofinnova Ventures; Shinya Yano, Astellas Venture Management; Peter Zhang, IDG Capital Partners Moderator: Christoph Westphal, Verastem |
| 2:30 - 3:00 pm | Networking Break |
| 3:00 - 3:45 pm | Legal, IP, Licensing and Partnership Tom Irving, Partner, Finnegan, LLP, ; Marc Rubenstein, Partner, Ropes & Gray, LLP |
| 3:45 - 4:30 pm | Pharmaceutical R&D Li Chen, Hua Medicine; Ruiping Dong, Merck; Steve Yang, AstraZeneca; Jingwu Zang, GlaxoSmithKline Moderator: Ge Li, WuXi Pharma |
| 4:30 - 5:30 pm | Networking Cocktails and Hors d’oeuvres Co-hosted by: Paul Bolno, GlaxoSmithKline; Nancy Chang, OrbiMed; Chun-lin Chen, Medicilon; Li Chen, Hua Medicine; Michelle Dipp, OvaScience; Samantha Du, Ge Li, WuXi Pharma; Joel Marcus, Alexandria Real Estate; Paul Schimmel, Scripps; Goro Takeda, Sofinnova Ventures; Christoph Westphal, Verastem; Steve Yang, Astrazeneca; Jingwu Zang, GlaxoSmithKline |
| Name | Address | Phone |
|---|---|---|
| Peninsula Shanghai | 32 Zhongshan Dong Yi Road, Shanghai, China |
| Name | Company |
|---|---|
| Paul Bolno | GlaxoSmithKline |
| Nancy Chang | OrbiMed |
| Chun-Lin Chen | Medicilon |
| Li Chen | Hua Medicine |
| Michelle Dipp | OvaScience |
| Samantha Du | |
| Robert Forrester | Verastem |
| Ge Li | WuXi PharmaTech |
| Joel Marcus | Alexandria Real Estate Equities |
| Robert Nelsen | ARCH Venture Partners |
| Paul Schimmel | Scripps |
| Goro Takeda | Sofinnova Ventures |
| Christoph Westphal | Verastem |
| Steve Yang | Astrazeneca |
| Jingwu Zang | GlaxoSmithKline |